Agenda

All times displayed for Europe/Berlin timezone.

BioProduction - Free to attend content

Bioproduction Keynote Presentations: Bioproduction Plenary Stage - 120A02
09:50 - 10:50 120F38
BioProduction Theatre

• 09:50 - 10:20 Keynote Presentation: Next Generation Biomanufacturing Facility Design and Optimisation
• 10:20-10:50 Keynote Presentation: Evolution of raw material developments and regulatory standards – from monoclonal drugs to cell and gene therapies

Speakers:
• Jeff Odum, Global Head of Design, Technology & Standards Biologics Engineering, Sanofi, USA
• Ger Brophy, Executive Vice President, Biopharma Production, Avantor, USA

Panel Discussion: Digitalisation and biomanufacturing 4.0 – strategies, enabling technologies and analytics to align and transform biopharmaceutical production in a digital era
11:50 - 12:20 120F38
BioProduction Theatre

Panellists:
• Moritz von Stosch, Senior Manager, Process Systems Biology and Engineering Center of Excellence, Technical R&D, GSK Biologicals, Belgium
• Michael Sokolov, Scientist and Lecturer, ETH Zurich, COO, DataHow, Switzerland

Spotlight Presentation: Available Slot
12:30 - 13:00 120F38
BioProduction Theatre

Please contact [email protected] for further details.

Live Labs: Join the Live Labs tour to gain an insight into some of the most innovative equipment and services to hit todays biopharmaceutical market
13:10 - 13:45 120F38
BioProduction Theatre

• 13:15 Live Lab Tour Presentation 1: W. L. Gore & Associates
• 13:25 Live Lab Tour Presentation 2: ALLpaQ Packaging
• 13:35 Live Lab Tour Presentation 3: Available Slot

Spotlight Presentation: Available Slot
13:50 - 14:20 120F38
BioProduction Theatre

Please contact [email protected] for further details.

Pharma Insight Briefings

AI for Drug Discovery – powered by ACS
10:30 - 11:40 61D61
CPhI Theatre
Vice President & Editor-in-Chief
C&EN Media Group
Chief Innovation Officer
CAS
Director of Virtual Human Project
Insilico Medicine

At the world’s pharma and biotech companies, artificial intelligence is increasingly critical to the drug discovery engine. A 2019 survey by the Pistoia Alliance found that 70% of life science researchers use AI, including machine and deep learning, in their work, up from 44% just two years earlier. But where along the road to a new drug will AI have the most impact? During this panel discussion experts from leading companies in the field will discuss and examine the hope and the hype--and what scientists need to know to understand what’s next.

Made to Order: 3D Printing for Personalized Medicines
10:30 - 11:40 120G43
ICSE Theatre
Co-founder and Director of Development
FabRx Ltd.
Senior Journalist
3D Printing Industry
Unit Manager Inspectorate Strategy & Innovation
Medicines and Healthcare products Regulatory Agency (MHRA)
Strategic Technology Bioconsulting
Independant
Senior Vice President & Chief Technology Officer
Aprecia Pharmaceuticals

As the Pharma industry shifts from volume to value – addressing smaller patient populations and orphan diseases, 3D printing technologies have a transformational role to play. With the promise of increasingly personalised and sophisticated solutions which offer significant benefits in terms of formulation, solubility and controlled release, what does the future hold?
• What are the current capabilities and the future potential?
• Impact for personalized medicines
• An overview of technologies on the market
• Case study – Aprecia Pharmaceuticals

Trends in Packaging & Devices for Biologics
10:30 - 11:40 110D50
InnoPack & P-MEC Theatre
Consultant, Thought Leadership
IQVIA
Vice President Drug Delivery Systems
Stevanato Group
Strategy & Innovation, Senior Global Product Manager
Schott Pharmaceutical Systems
Director, Global Business Development, Injectables Divsion
Aptar Pharma
CEO
Sorrel Medical

Sponsored by:

[In collaboration with Pharmapack Europe]
With more and more biologics coming to market, packaging companies must innovate to ensure these complex products with very specific needs will be safely delivered to patients. This panel will provide an overview on the latest trends and developments in this sector.

The case for a Master File System for Novel Excipients in Europe
11:50 - 12:20 61D61
CPhI Theatre

Sponsored by:

The Role of the Pharmaceutical Industry in Humanitarian Relief
11:50 - 12:20 110D50
InnoPack & P-MEC Theatre
Director, Middle East and North Africa and GCC Affairs
International Medical Corps

Sponsored by:

International Medical Corps, a global humanitarian organization, provides disaster relief and recovery around the world. Across responses, the organization has utilized support from the pharmaceutical industry to reach women, men, and children in need. Join this discussion to hear more about humanitarian response and the intersection with the pharmaceutical industry.

Innovative Methods and Technologies for Synthesis of Novel Pharmacophores
11:50 - 12:20 120G43
ICSE Theatre

Sponsored by:

In the modern drug discovery, several innovative modelsand technology wereintroduced such as scaffold hopping,escape flatland, conformational restriction and chemical equivalents. It has gained a significant recognition in the scientific community. In this perspective, scientists are currently looking for novel attractive molecules for the synthesis and exploration in the drug discovery. The development of the new methodologies for key pharmacophoremotifs will be accelerate the designing process of active APIs. In the recent years, we have designed and demonstrated several new asymmetric methodologies for following key pharmacophore motifs

Cannabis Extracts and Cannabidiol: Two ingredients, multiple applications, tangible results and quality
12:30 - 13:00 61D61
CPhI Theatre
MD, Nefróloga y Farmacóloga
Universidad de la República, Uruguay
Post Doc at the Parker Institute
Linea

Linnea is honored to present two experts in cannabis extracts and cannabidiol who will clarify these natural ingredients’ potential. Since ancient times, cannabis’ therapeutic benefits have been recognized, yet in the early 20th century, the plant became controversial and was subjected to legal restrictions. The bans are now being lifted, allowing research to proceed on cannabis’ effectiveness in treating diseases and symptoms.

Linnea’s brand Theca is conducting research into this rediscovered plant. The company has decades of experience in the herbal extracts market, processing natural ingredients for the pharmaceutical industry. This knowledge is proving an enormous benefit as we delve into this cutting-edge field. We are committed to standardization for ensuring that our high-quality products are safe and effective.

Our guests will detail the latest research findings. MD Leticia CuÑetti Delmonte, an associate professor of pharmacology and therapeutics at the Uruguay School of Medicine, will present data on the use of standardized cannabis extracts. PhD Marianne Uggen Rasmussen, will give a comprehensive overview of pure cannabidiol’s application and research results in northern European countries.

Fluorination expert in small molecules pharma CDMO - From early stage to commercial GMP production
12:30 - 13:00 120G43
ICSE Theatre
Director, Sales & Business Development
AGC Pharma Chemicals Europe
Manager, Global Business Development, Pharmaceutical Divisio
AGC Chemicals

Sponsored by:

Medical Cannabis, the next generation is here- from flowers to pharmaceutical products
13:10 - 13:40 61D61
CPhI Theatre
CEO
Panaxia Pharmaceuticals Ltd

Sponsored by:

This session will explain how the industry tends to achieve the transition from medicinal to pharmaceutical cannabis for a range of specific products and indications. Particular attention will be given to the challenge of using cannabis flowers as an Active Ingredient, employed advanced technology, and standardized finished product's' quality.

How Supply Chain Security and Quality Initiatives Intersect
13:10 - 13:40 120G43
ICSE Theatre
Chief Executive Officer
Rx-360

Sponsored by:

This presentation will provide the audience with an overview of the importance of pharmaceutical supply chain security and how it intersects with quality initiatives. With the demand for quality at an all time high from both regulators and industry its important to understand how two major components of this are fit together

- What really is supply chain security
- How is “quality” defined and how is success measured in quality initiatives
- How does quality and supply chain security interact
- How to build a matrixed environment internally at your organization between these two arenas

Pharma packaging meets IoT
13:10 - 13:40 110D50
InnoPack & P-MEC Theatre
Co-Founder, Senior VP Sales and Business Development
Nolato Pharma Packaging
Managing Director
Nolato Pharma Packaging

Sponsored by: